01063nam0-2200349li-450 99000016887020331620180312154722.00-471-85362-30016887USA010016887(ALEPH)000016887USA01001688720001109d1990----km-y0itay0103----baengUSPrinciples of polymer engineering rheologyJames Lindsay WhiteNew York [etc.]John Wiley & Sonscopyr. 1990VII, 326 p.ill.24 cmpolimeri e polimerizzazione reologia6689.White,James Lindsay747060Sistema bibliotecario di Ateneo dell' Università di SalernoRICA990000168870203316668.9 WHI0000993BKTEC1991052720001110USA01171220020403USA011624PATRY9020040406USA011612Principles of polymer engineering rheology1491932UNISA05570nam 2200733Ia 450 991102007420332120200520144314.09786612307041978128230704912823070459783527623860352762386897835276238773527623876(CKB)1000000000799524(EBL)481429(SSID)ssj0000294343(PQKBManifestationID)11195940(PQKBTitleCode)TC0000294343(PQKBWorkID)10322607(PQKB)10519302(MiAaPQ)EBC481429(OCoLC)476317498(PPN)243292252(Perlego)2758651(EXLCZ)99100000000079952420080616d2009 uy 0engur|n|---|||||txtccrDrug bioavailability estimation of solubility, permeability, absorption and bioavailability2nd, completely rev. ed /edited by Han van de Waterbeemd and Bernard Testa.Weinheim Wiley-VCHc20091 online resource (653 p.)Methods and principles in medicinal chemistry ;40Description based upon print version of record.9783527320516 3527320512 Includes bibliographical references and index.Drug Bioavailability: Estimation of Solubility, Permeability, Absorption and Bioavailability; Contents; List of Contributors; Preface; A Personal Foreword; 1 Introduction: The Why and How of Drug Bioavailability Research; 1.1 Dening Bioavailability; 1.1.1 The Biological Context; 1.1.2 A Pharmacokinetic Overview; 1.1.3 Specic Issues; 1.2 Presentation and Layout of the Book; References; Part One Physicochemical Aspects of Drug Dissolution and Solubility; 2 Aqueous Solubility in Drug Discovery Chemistry, DMPK, and Biological Assays; 2.1 Introduction; 2.1.1 Denition of Aqueous Solubility2.1.2 Aqueous Solubility in Different Phases of Drug Discovery2.2 Aqueous Solubility in Hit Identication; 2.2.1 Aqueous Solubility from DMSO Solutions; 2.2.1.1 Turbidimetric Methods; 2.2.1.2 UV Absorption Methods; 2.2.1.3 Alternative Detection Methodology; 2.2.1.4 Application of DMSO-Based Solubility Assays; 2.3 Aqueous Solubility in Lead Identication and Lead Optimization; 2.3.1 Dried-Down Solution Methods; 2.3.2 Solubility from Solid; 2.3.3 Thermodynamic Solubility Assays with Solid-State Characterization; 2.3.4 Solubility by Potentiometry2.3.5 Application of Thermodynamic Solubility Data in LI and LO2.4 Conclusions; References; 3 Gastrointestinal Dissolution and Absorption of Class II Drugs; 3.1 Introduction; 3.2 Drug Absorption and the BCS; 3.3 Class II Drugs; 3.4 GI Physiological Variables Affecting Class II Drug Dissolution; 3.4.1 Bile Salts; 3.4.2 GI pH; 3.4.3 GI Transit; 3.4.4 Drug Particle Size; 3.4.5 Volume Available for Dissolution; 3.5 In Vitro Dissolution Tests for Class II Drugs; 3.5.1 Biorelevant Media; 3.5.2 Dynamic Lipolysis Model; 3.6 BCS-Based FDA Guidelines: Implications for Class II Drugs3.6.1 Potential of Redening BCS Solubility Class Boundary3.6.2 Biowaiver Extension Potential for Class II Drugs; 3.7 Conclusions; References; 4 In Silico Prediction of Solubility; 4.1 Introduction; 4.2 What Solubility Measures to Model?; 4.3 Is the Data Set Suitable for Modeling?; 4.4 Descriptors and Modeling Methods for Developing Solubility Models; 4.5 Comparing Literature Solubility Models; 4.6 What Is the Inuence of the Domain of Applicability?; 4.7 Can We Tell when Good Predictions Are Made?; 4.8 Conclusions; ReferencesPart Two Physicochemical and Biological Studies of Membrane Permeability and Oral Absorption5 Physicochemical Approaches to Drug Absorption; 5.1 Introduction; 5.2 Physicochemical Properties and Pharmacokinetics; 5.2.1 DMPK; 5.2.2 Lipophilicity, Permeability, and Absorption; 5.2.3 Estimation of Volume of Distribution from Physical Chemistry; 5.2.4 Plasma Protein Binding and Physicochemical Properties; 5.3 Dissolution and Solubility; 5.3.1 Calculated Solubility; 5.4 Ionization (pKa); 5.4.1 Calculated pKa; 5.5 Molecular Size and Shape; 5.5.1 Calculated Size Descriptors; 5.6 Hydrogen Bonding5.6.1 Calculated Hydrogen-Bonding DescriptorsThe gold standard for industrial research now completely revised in line with current trends in the field, with all contributions extensively updated or rewritten. In 21 chapters readers can benefit from the key working knowledge of today's leading pharmaceutical companies, including Pfizer, AstraZeneca, and Roche. Drug developers from industry and academia present all the factors governing drug bioavailability, complete with practical examples and real-life data. Part I focuses on in vitro and in vivo measurements of physicochemical properties, such as membrane permeability and ionizaMethods and principles in medicinal chemistry ;40.DrugsBioavailabilityPharmaceutical chemistryDrugsBioavailability.Pharmaceutical chemistry.615.19664.06Waterbeemd Han van de860600Testa Bernard290760MiAaPQMiAaPQMiAaPQBOOK9911020074203321Drug bioavailability4421820UNINA